Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.
Identifieur interne : 000A00 ( PubMed/Curation ); précédent : 000999; suivant : 000A01Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.
Auteurs : Tekola Endeshaw [Éthiopie] ; Aseged Taye ; Zerihun Tadesse ; Moses N. Katabarwa ; Oumer Shafi ; Tewodros Seid ; Frank O. RichardsSource :
- Pathogens and global health [ 2047-7732 ] ; 2015.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Animaux, Antiparasitaires (administration et posologie), Antiparasitaires (usage thérapeutique), Calendrier d'administration des médicaments, Enfant, Enfant d'âge préscolaire, Femelle, Filariose lymphatique (), Filariose lymphatique (transmission), Filariose lymphatique (épidémiologie), Humains, Ivermectine (administration et posologie), Ivermectine (usage thérapeutique), Maladies endémiques (), Microfilaria (isolement et purification), Mâle, Onchocercose (), Prévalence, Répartition par sexe, Répartition par âge, Sujet âgé, Utilisation médicament (), Wuchereria bancrofti, Éthiopie (épidémiologie).
- MESH :
- administration et posologie : Antiparasitaires, Ivermectine.
- isolement et purification : Microfilaria.
- usage thérapeutique : Antiparasitaires, Filariose lymphatique, Ivermectine.
- épidémiologie : Filariose lymphatique, Éthiopie.
- Adolescent, Adulte, Adulte d'âge moyen, Animaux, Calendrier d'administration des médicaments, Enfant, Enfant d'âge préscolaire, Femelle, Filariose lymphatique, Humains, Maladies endémiques, Mâle, Onchocercose, Prévalence, Répartition par sexe, Répartition par âge, Sujet âgé, Utilisation médicament, Wuchereria bancrofti.
English descriptors
- KwdEn :
- Adolescent, Adult, Age Distribution, Aged, Animals, Antiparasitic Agents (administration & dosage), Antiparasitic Agents (therapeutic use), Child, Child, Preschool, Drug Administration Schedule, Drug Utilization (statistics & numerical data), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Elephantiasis, Filarial (transmission), Endemic Diseases (prevention & control), Ethiopia (epidemiology), Female, Humans, Ivermectin (administration & dosage), Ivermectin (therapeutic use), Male, Microfilariae (isolation & purification), Middle Aged, Onchocerciasis (prevention & control), Prevalence, Sex Distribution, Wuchereria bancrofti.
- MESH :
- chemical , administration & dosage : Antiparasitic Agents, Ivermectin.
- chemical , therapeutic use : Antiparasitic Agents, Ivermectin.
- epidemiology : Elephantiasis, Filarial, Ethiopia.
- isolation & purification : Microfilariae.
- prevention & control : Elephantiasis, Filarial, Endemic Diseases, Onchocerciasis.
- statistics & numerical data : Drug Utilization.
- transmission : Elephantiasis, Filarial.
- Adolescent, Adult, Age Distribution, Aged, Animals, Child, Child, Preschool, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Prevalence, Sex Distribution, Wuchereria bancrofti.
Abstract
There is considerable interest in determining whether mass drug administration (MDA) with ivermectin for onchocerciasis control will eliminate coendemic lymphatic filariasis (LF). The objective of this study was to determine the prevalence of LF microfilaremia in onchocerciasis endemic districts that had received 7 years of MDA with ivermectin.
DOI: 10.1080/20477724.2015.1103501
PubMed: 26878935
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000A00
Links to Exploration step
pubmed:26878935Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.</title><author><name sortKey="Endeshaw, Tekola" sort="Endeshaw, Tekola" uniqKey="Endeshaw T" first="Tekola" last="Endeshaw">Tekola Endeshaw</name><affiliation wicri:level="1"><nlm:affiliation>1 The Carter Center, Addis Ababa , Ethiopia.</nlm:affiliation><country xml:lang="fr">Éthiopie</country><wicri:regionArea>1 The Carter Center, Addis Ababa </wicri:regionArea></affiliation></author><author><name sortKey="Taye, Aseged" sort="Taye, Aseged" uniqKey="Taye A" first="Aseged" last="Taye">Aseged Taye</name></author><author><name sortKey="Tadesse, Zerihun" sort="Tadesse, Zerihun" uniqKey="Tadesse Z" first="Zerihun" last="Tadesse">Zerihun Tadesse</name></author><author><name sortKey="Katabarwa, Moses N" sort="Katabarwa, Moses N" uniqKey="Katabarwa M" first="Moses N" last="Katabarwa">Moses N. Katabarwa</name></author><author><name sortKey="Shafi, Oumer" sort="Shafi, Oumer" uniqKey="Shafi O" first="Oumer" last="Shafi">Oumer Shafi</name></author><author><name sortKey="Seid, Tewodros" sort="Seid, Tewodros" uniqKey="Seid T" first="Tewodros" last="Seid">Tewodros Seid</name></author><author><name sortKey="Richards, Frank O" sort="Richards, Frank O" uniqKey="Richards F" first="Frank O" last="Richards">Frank O. Richards</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26878935</idno><idno type="pmid">26878935</idno><idno type="doi">10.1080/20477724.2015.1103501</idno><idno type="wicri:Area/PubMed/Corpus">000A00</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A00</idno><idno type="wicri:Area/PubMed/Curation">000A00</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A00</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.</title><author><name sortKey="Endeshaw, Tekola" sort="Endeshaw, Tekola" uniqKey="Endeshaw T" first="Tekola" last="Endeshaw">Tekola Endeshaw</name><affiliation wicri:level="1"><nlm:affiliation>1 The Carter Center, Addis Ababa , Ethiopia.</nlm:affiliation><country xml:lang="fr">Éthiopie</country><wicri:regionArea>1 The Carter Center, Addis Ababa </wicri:regionArea></affiliation></author><author><name sortKey="Taye, Aseged" sort="Taye, Aseged" uniqKey="Taye A" first="Aseged" last="Taye">Aseged Taye</name></author><author><name sortKey="Tadesse, Zerihun" sort="Tadesse, Zerihun" uniqKey="Tadesse Z" first="Zerihun" last="Tadesse">Zerihun Tadesse</name></author><author><name sortKey="Katabarwa, Moses N" sort="Katabarwa, Moses N" uniqKey="Katabarwa M" first="Moses N" last="Katabarwa">Moses N. Katabarwa</name></author><author><name sortKey="Shafi, Oumer" sort="Shafi, Oumer" uniqKey="Shafi O" first="Oumer" last="Shafi">Oumer Shafi</name></author><author><name sortKey="Seid, Tewodros" sort="Seid, Tewodros" uniqKey="Seid T" first="Tewodros" last="Seid">Tewodros Seid</name></author><author><name sortKey="Richards, Frank O" sort="Richards, Frank O" uniqKey="Richards F" first="Frank O" last="Richards">Frank O. Richards</name></author></analytic><series><title level="j">Pathogens and global health</title><idno type="eISSN">2047-7732</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Distribution</term><term>Aged</term><term>Animals</term><term>Antiparasitic Agents (administration & dosage)</term><term>Antiparasitic Agents (therapeutic use)</term><term>Child</term><term>Child, Preschool</term><term>Drug Administration Schedule</term><term>Drug Utilization (statistics & numerical data)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Elephantiasis, Filarial (transmission)</term><term>Endemic Diseases (prevention & control)</term><term>Ethiopia (epidemiology)</term><term>Female</term><term>Humans</term><term>Ivermectin (administration & dosage)</term><term>Ivermectin (therapeutic use)</term><term>Male</term><term>Microfilariae (isolation & purification)</term><term>Middle Aged</term><term>Onchocerciasis (prevention & control)</term><term>Prevalence</term><term>Sex Distribution</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Antiparasitaires (administration et posologie)</term><term>Antiparasitaires (usage thérapeutique)</term><term>Calendrier d'administration des médicaments</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (transmission)</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Ivermectine (administration et posologie)</term><term>Ivermectine (usage thérapeutique)</term><term>Maladies endémiques ()</term><term>Microfilaria (isolement et purification)</term><term>Mâle</term><term>Onchocercose ()</term><term>Prévalence</term><term>Répartition par sexe</term><term>Répartition par âge</term><term>Sujet âgé</term><term>Utilisation médicament ()</term><term>Wuchereria bancrofti</term><term>Éthiopie (épidémiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparasitic Agents</term><term>Ivermectin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparasitic Agents</term><term>Ivermectin</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antiparasitaires</term><term>Ivermectine</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Ethiopia</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Microfilariae</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Microfilaria</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Endemic Diseases</term><term>Onchocerciasis</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Drug Utilization</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiparasitaires</term><term>Filariose lymphatique</term><term>Ivermectine</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Éthiopie</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Distribution</term><term>Aged</term><term>Animals</term><term>Child</term><term>Child, Preschool</term><term>Drug Administration Schedule</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Sex Distribution</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Calendrier d'administration des médicaments</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Filariose lymphatique</term><term>Humains</term><term>Maladies endémiques</term><term>Mâle</term><term>Onchocercose</term><term>Prévalence</term><term>Répartition par sexe</term><term>Répartition par âge</term><term>Sujet âgé</term><term>Utilisation médicament</term><term>Wuchereria bancrofti</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There is considerable interest in determining whether mass drug administration (MDA) with ivermectin for onchocerciasis control will eliminate coendemic lymphatic filariasis (LF). The objective of this study was to determine the prevalence of LF microfilaremia in onchocerciasis endemic districts that had received 7 years of MDA with ivermectin.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26878935</PMID><DateCreated><Year>2016</Year><Month>02</Month><Day>16</Day></DateCreated><DateCompleted><Year>2016</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2047-7732</ISSN><JournalIssue CitedMedium="Internet"><Volume>109</Volume><Issue>7</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Pathogens and global health</Title><ISOAbbreviation>Pathog Glob Health</ISOAbbreviation></Journal><ArticleTitle>Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.</ArticleTitle><Pagination><MedlinePgn>344-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/20477724.2015.1103501</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is considerable interest in determining whether mass drug administration (MDA) with ivermectin for onchocerciasis control will eliminate coendemic lymphatic filariasis (LF). The objective of this study was to determine the prevalence of LF microfilaremia in onchocerciasis endemic districts that had received 7 years of MDA with ivermectin.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Three villages with a 2010 LF circulating antigenaemia prevalence (determined in a mapping exercise using immunochromatography tests) ranging from 23 to 56% were surveyed for the presence of Wuchereria bancrofti microfilaria (mf) in 2012. These villages had been treated with ivermectin MDA for onchocerciasis with reported total population coverage of ≥65%. A total of 774 residents aged 2 years and above, of both genders, provided 60 μl nocturnal blood samples between 10 pm and 2 am. Standard thick smears were prepared and examined microscopically after Giemsa staining for the presence of W. bancrofti mf.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean mf prevalence was 4.7% (village range 1.1-11.0%). The mean mf density was 9.8 mf/60 μl (village range 9-13.1) among the positive individuals. Children in the 2-4-year-old and 5-9-year-old age groups were infected suggesting transmission occurred during the MDA period. A village level review of MDA treatment coverage records showed an average total population coverage of 66.4% over a 7-year period, but with a considerable range of annual coverage (43.0-89.9%). In addition, village level treatment coverage data were missing from the village with the highest mf prevalence (11%) for 2 of the 7 years.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">7 years of annual mass treatment with ivermectin monotherapy for onchocerciasis did not interrupt LF transmission. In expanding the onchocerciasis ivermectin MDA programme to include LF, albendazole should be added and treatment coverage improved.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Endeshaw</LastName><ForeName>Tekola</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>1 The Carter Center, Addis Ababa , Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taye</LastName><ForeName>Aseged</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Tadesse</LastName><ForeName>Zerihun</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Katabarwa</LastName><ForeName>Moses N</ForeName><Initials>MN</Initials></Author><Author ValidYN="Y"><LastName>Shafi</LastName><ForeName>Oumer</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Seid</LastName><ForeName>Tewodros</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>Frank O</ForeName><Initials>FO</Initials><Suffix>Jr</Suffix></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pathog Glob Health</MedlineTA><NlmUniqueID>101583421</NlmUniqueID><ISSNLinking>2047-7724</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000977">Antiparasitic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>70288-86-7</RegistryNumber><NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2005 Jul 15;4:6</RefSource><PMID Version="1">16022728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2012 Aug;87(2):216-22</RefSource><PMID Version="1">22855750</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013;7(9):e2433</RefSource><PMID Version="1">24069488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Opin Pharmacother. 2005 Feb;6(2):179-200</RefSource><PMID Version="1">15757416</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2014 Sep 19;89(38):409-18</RefSource><PMID Version="1">25243263</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2001 Aug;65(2):108-14</RefSource><PMID Version="1">11508383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2012 Feb;106(2):117-27</RefSource><PMID Version="1">22154976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ethiop Med J. 1976 Apr;14(2):31-6</RefSource><PMID Version="1">976247</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2003 Dec;97(8):827-38</RefSource><PMID Version="1">14754495</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2005 Oct;10(10):1002-4</RefSource><PMID Version="1">16185234</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2015 May 30;385(9983):2151-2</RefSource><PMID Version="1">26068266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013;7(12):e2584</RefSource><PMID Version="1">24340120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ethiop Med J. 1995 Jul;33(3):143-53</RefSource><PMID Version="1">7588653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Health. 2016 Feb;8(2):116-23</RefSource><PMID Version="1">26152231</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Vet Entomol. 2002 Dec;16(4):409-23</RefSource><PMID Version="1">12510894</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasitol Today. 1997 Oct;13(10):401-4</RefSource><PMID Version="1">15275155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2010 Sep 14;3:85</RefSource><PMID Version="1">20840757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Trop Med. 2010;2010:null</RefSource><PMID Version="1">20936103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Geogr Med. 1973 Sep;25(3):300-3</RefSource><PMID Version="1">4752246</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2014 Apr 11;89(15):153-60</RefSource><PMID Version="1">24754045</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013;7(10):e2508</RefSource><PMID Version="1">24205421</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000977" MajorTopicYN="N">Antiparasitic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004363" MajorTopicYN="N">Drug Utilization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019353" MajorTopicYN="N">Endemic Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005002" MajorTopicYN="N">Ethiopia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008842" MajorTopicYN="N">Microfilariae</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009855" MajorTopicYN="N">Onchocerciasis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014958" MajorTopicYN="Y">Wuchereria bancrofti</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC4768627 [Available on 10/01/16]</OtherID><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Annual MDA</Keyword><Keyword MajorTopicYN="N">Elimination</Keyword><Keyword MajorTopicYN="N">Ivermectin</Keyword><Keyword MajorTopicYN="N">Lymphatic filariasis</Keyword><Keyword MajorTopicYN="N">Onchocerciasis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26878935</ArticleId><ArticleId IdType="doi">10.1080/20477724.2015.1103501</ArticleId><ArticleId IdType="pmc">PMC4768627</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A00 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000A00 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:26878935
|texte= Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:26878935" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |